Fight for Sight is working to raise awareness of the importance of eye donations after research has found that eyes are the organ that people would be the least likely to donate following their death.
The eye research charity has highlighted that there is currently a shortfall in corneas that can be used for transplant, with statistics released by NHS Blood and Transplant this month reporting that there are currently 279 corneas in eye banks, despite the target being to have around 350 at all times.
Author: David Gable
AGM Report
Our well attended, AGM was held on 23rd March 2019.
Three new committee members were appointed namely, Batcho Notay, Caroline Condillac and Jacqui Thomas. Moira O’Brien resigned for health reasons. The meeting paid tribute to Moira who has been a supporter of the KC group since its inception. Click here to see a full list of officials.
The Chairmans report is available here
The meeting was followed by a fascinating talk by Alison Hardcastle, Professor of Molecular Genetics at the Institute of Ophthalmology Faculty of Brain Sciences, who spoke about the Moorfields genetic study.
To read the research summary published by UCL INSTITUTE OF OPHTHALMOLOGY- click here
Brighton Branch Meeting
Brighton Keratoconus Support Group
Our next meeting will take place on:
Saturday 9th November 2019 at 11am
at the
Sussex Eye Hospital
Eastern Road
Brighton BN2 5BF
(in the Dr’s Mess which is on the Ground Floor and immediately opposite the main entrance to the Eye Hospital)
|
For further details please ring David Gable on 020 8554 5578
Car Parking – It has been suggested that it is cheaper to park free at the Marina and get the No. 7 bus to the hospital (5 minutes)
How many people have keratoconus?
This is an interesting article published by the National Keratoconus Foundation in America:
For many years, it’s been long stated that keratoconus occurs in one person in every 2,000. In an article published in March 2017, the American Journal of Ophthalmology, Dr. Daniel Godefrooij, from the University of Utrecht, refines our understanding of incidence and prevalence of KC(2).
The analysis that KC occurs in 1 in every 2,000 people was derived from a patient registry that was initiated in part by NKCF, over the span of fifty years from the 1930s to the 1980s. Some early supporters of NKCF likely participated in the voluntary survey. Read More…
Fight for Sight / Keratoconus Group Small Grant Award
We are pleased to announce that we have entered in to an agreement with Fight for Sight to support an award up to the value of £15,000 to fund research into the condition Keratoconus.
The Award will be funded as to 50% by Keratoconus Group and 50% by Fight for Sight.
Latest Update
We can now announce that the funding has been awarded to a team led by Dr Mouhamed Al-Aqaba at Nottingham University . The project is titled – “The involvement of corneal nerves in the pathogenesis and progression of keratoconus”. The research team has already identified that corneal nerves are dramatically altered in KC and will now be looking at whether these changes have a relation to the severity and progression of KC and identifying the types of nerves involved. This promises to increase the understanding of the condition, and may eventually lead to new interventions.
This is an exciting adventure made possible by the generous sponsorship of Barbican Insurance.
For full details are on the the Fight for Sight website – Here
Concert in aid of KC research

Australian viola player Michelle Urquhart and her friend Marco van Pagee gave a delightful solo viola and viola duet recital.
“It was whilst studying music at the Sydney Conservatorium that Michelle’s eyesight started to fail. She underwent her first corneal graft. It failed, and for four and a half years she was legally blind. Following serious eye infections and rejection she underwent an emergency graft.Sight restored, Michelle threw herself back into her music. ‘Having my sight taken away and then having a second chance at music with my successful transplants has been a miracle and the great gift of my life. I want to make the most of every moment and share my music with the world, and support others with Keratoconus.’ “
Solo Eye Drop Treatment in Development for Keratoconus
At our last AGM, Professor Roger Buckley told us about an exciting new development which could lead to non-invasive eye drops being used to stop the progression of keratoconus – a pharmacological version of CXL.
A description of his talk may be found in our Summer 2018 Newsletter.
You can read more about this research in this scientific journal.
Visualise Resource Pack
Visualise is a charity that helps organisations find the answers that make their services more inclusive and accessible to people with a visual impairment and other disabilities. As leaders in their field, they bring extensive experience and knowledge of disability, both personally and professionally, to business and organisations.
To access the Resource Pack For Health & Social Care Professionals Supporting People With Sight Loss
– Click on this link
Newcastle University 3D Print World’s First Human Corneas
The first human corneas have been 3D printed by scientists at Newcastle University.
It means the technique could be used in the future to ensure an unlimited supply of corneas.
Moorfields CXL Results
Moorfields have carried out 4,620 Corneal Collagen Crosslinking treatments and have recently published their results. View the results.